Saturday 17 October 2026
Export QHCQQ’s income statement to Excel — free account
Quorum Health Corporation
Follow QHCQQ
| Older periods | Jun '19 | Sep '19 | Dec '19 | Mar '20 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.02 | 0.02 | 0.02 | 0.01 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(3.95) | 1.45 | (0.52) | (1.57) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.69 | 0.67 | 0.74 | 0.80 | |
EV/EBITDA |
19.72 | 28.06 | 43.05 | 0.00 | |
EV/Operating CF |
55.39 | 61.27 | (38.27) | (25.47) | |
EV/FCF |
(58.95) | (49.75) | (15.63) | (12.68) | |
Quick Ratio |
0.84 | 0.89 | 0.19 | 0.19 | |
Current Ratio |
1.43 | 1.21 | 0.26 | 0.26 | |
Net Debt/EBITDA |
38.17 | (42.74) | 76.64 | (35.63) | |
Debt/Assets |
77.30% | 78.66% | 82.61% | 86.28% | |
Debt/Equity |
(9.34) | (5.89) | (5.22) | (4.08) | |
Asset Turnover |
1.12 | 1.13 | 1.10 | 1.01 | |
Operating CF/Net income |
0.62 | (0.33) | 1.73 | 0.11 | |
Capex/Depreciation |
(0.84) | (0.64) | (1.22) | (0.98) | |
Interest Coverage |
0.51 | (1.27) | 0.08 | (1.48) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
48.26% | 51.31% | 47.85% | 51.27% | |
Intangible Assets out of Total Assets |
0.28 | 0.29 | 0.30 | 0.30 | |
Share Based Compensation of Revenue |
0.27% | 0.42% | 0.16% | 0.31% | |
Graham Net Nets |
(30.06) | (34.98) | (45.86) | (100.37) | |
Graham Number |
20.81 | 27.86 | 31.12 | 39.55 | |
Earnings Yield |
(324.82%) | (423.14%) | (533.33%) | (1,560.00%) | |
Free Cash Flow Yield |
(51.63%) | (65.46%) | (279.95%) | (727.01%) | |
Revenue per Share |
14.74 | 13.91 | 12.84 | 11.27 | |
Operating CF per Share |
(0.35) | 0.83 | (1.86) | (0.29) | |
Capex per Share |
(0.40) | (0.32) | (0.55) | (0.39) | |
Free Cash Flow per Share |
(0.75) | 0.52 | (2.41) | (0.68) | |
Cash per Share |
0.08 | 1.47 | 0.11 | 1.03 | |
Shareholders Equity per Share |
(4.33) | (6.74) | (7.88) | (10.31) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(4.33) | (6.74) | (7.88) | (10.31) | |
Free Cash Flow |
(22.54) | 15.59 | (72.15) | (20.73) | |
Working Capital |
138.14 | 77.36 | (1,141.75) | (1,203.42) | |
Capital Expenditures |
(12.14) | (9.56) | (16.44) | (11.99) | |
Net Current Asset Value |
(1,235.68) | (1,277.17) | (1,318.84) | (1,378.21) | |
EV/EBIT |
726.48 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.02 | 0.04 | 0.03 | |
Price to Operating Income |
23.87 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
299.20 | 300.99 | 304.75 | 298.73 | |
Average Payables |
147.67 | 150.02 | 150.29 | 155.18 | |
Average Inventory |
44.11 | 43.14 | 42.20 | 41.23 | |
Average Assets |
1,616.40 | 1,567.45 | 1,532.99 | 1,567.35 | |
Average Common Equity |
(69.20) | (131.83) | (155.46) | (214.33) |
Columns are period end dates